| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |